Today's Healthcare Pulse
Allogene Therapeutics CEO David Chang to step down
Allogene Therapeutics announced that chief executive David Chang will leave his role. The news was reported by STAT+ and echoed in a follow‑up piece covering broader pharma updates.
Also developing:
By the numbers: Boston Scientific invests $1.5B for 34% stake in MiRus
STAT+: Pharmalittle: We’re Reading About the FDA Warning Novo Nordisk, Lilly Investing in China, and More
Astellas Pharma leveraged the Trump administration’s push for lower U.S. drug prices to argue for higher reimbursement for its eye drug Izervay in Japan, winning a more generous price level. Meanwhile, a review of FDA adverse event reports found that the obesity drug Wegovy carries nearly a fivefold higher risk of ischemic optic neuropathy (ION) compared with the diabetes drug Ozempic, despite both containing semaglutide. The analysis also revealed men experience three times the ION risk of women, and the risk is not listed on U.S. product labels but is noted as very rare by the European Medicines Agency. These developments highlight how policy and safety data are reshaping pharmaceutical pricing and risk communication.
Coloplast Names Former J&J Executive Gavin Wood as CEO
Coloplast announced that former Johnson & Johnson executive Gavin Wood will assume the role of chief executive officer on May 1, ending a ten‑month search for a permanent leader. Wood arrives after serving as J&J’s group chairman for MedTech across Europe,...
Equatorial Guinea’s Malaria Elimination Vision 2030 Could Unlock Tourism Growth
Equatorial Guinea has launched a $116 million Vision 2030 malaria elimination strategy, building on two decades of success on Bioko Island where prevalence fell to 7.2 % in 2025. The programme aims to eradicate malaria nationwide, improve public‑health outcomes and remove a key...
FDA Adverse Event Monitoring System (AEMS) Electronic Submissions
The FDA is rolling out the Adverse Event Monitoring System (AEMS), replacing the legacy FAERS platform and consolidating reporting across drugs, biologics, devices, cosmetics, food, tobacco, and veterinary products. AEMS introduces standardized electronic submissions, AI‑driven redaction and analytics, and a...
HIMSS26: CharmHealth Launches CharmCopilot, an Embedded Multi-Agent AI Assistant for EHR Workflows
CharmHealth has introduced CharmCopilot, an embedded multi‑agent AI assistant built directly into its electronic health record platform. The company is offering the core AI capabilities to existing customers at no additional charge, positioning the tool as a cost‑disruptive solution. Its...
FDA Adverse Event Monitoring System (AEMS)
The FDA is launching the Adverse Event Monitoring System (AEMS) to replace the legacy FAERS platform and bring together reporting for drugs, vaccines, devices, food, cosmetics, tobacco, and veterinary products. AEMS introduces standardized reporting protocols, AI‑driven redaction and digitization, and...
Why Staff Safety Is the Foundation of Clinical Excellence
Healthcare organizations must prioritize staff safety to achieve clinical excellence. Research shows physical and psychological safety are top predictors of patient safety grades, and a 10% rise in staff turnover intent correlates with a 14% increase in inpatient mortality. Burnout...
Boron Chemistry Breaks Protein Synthesis Barrier, May Aid Cancer Therapies
Researchers at ETH Zurich have introduced a boron‑based ligation strategy that overcomes the concentration barrier in chemical protein synthesis. By masking potassium acyltrifluoroborates (KATs) with chiral zwitterionic complexes, the team achieved efficient peptide coupling at micromolar levels, far lower than...
Stamford Health Selects Ensemble Health Partners for End-to-End RCM Operations
Stamford Health, a 305‑bed independent system in Connecticut, has chosen Ensemble Health Partners to run its end‑to‑end revenue cycle management. Ensemble will apply its integrated operating model, AI‑driven analytics, and existing EHR infrastructure to automate billing, coding and denial recovery....
HIMSS26: Imprivata Introduces Agentic Identity Management to Secure and Govern AI Agents
Imprivata unveiled Agentic Identity Management at HIMSS26, a platform that secures and governs AI agents used in clinical documentation, prior authorizations, and triage. The solution treats AI agents as managed identities, issuing short‑lived tokens and enforcing least‑privilege access across both...
Could a Hot Cup of Matcha Dial Down the 'Sneeze Switch' In Allergic Rhinitis?
A recent early‑access study published in npj Science of Food reports that oral matcha consumption reduced sneezing in mice engineered to exhibit allergic rhinitis. The mice received matcha tea two to three times weekly for over five weeks and a...
Chiesi and Bespak Partner to Advance Carbon Minimal Inhaler Production With UK Manufacturing Site
Chiesi Group and inhalation CDMO Bespak have expanded their long‑standing partnership by increasing pressurized metered‑dose inhaler (pMDI) manufacturing capacity at Bespak’s Holmes Chapel, UK site. The move supports Chiesi’s Carbon Minimal Inhaler (CMI) program, which targets up to a 90 %...
Beyond the “Overdiagnosis” Narrative: Understanding Adult ADHD Through DSM-5
The letter challenges the claim that adult ADHD is overdiagnosed, arguing that the DSM‑5’s broader criteria simply correct a historic underdiagnosis. It highlights that clinicians often lack the training and time needed for comprehensive neuropsychological assessments, leading to diagnostic shortcuts....
Alignment with Data Exchange Standards Is a Must for Digital Transformation
At HIMSS26, Sequoia Project’s Didi Davis unveiled the second USCDI v3 data‑usability guide, expanding coverage to all data classes and emphasizing provenance, traceability, and persistent identifiers. The 60‑page guide outlines use cases across provider‑to‑provider, provider‑to‑public‑health, and provider‑to‑consumer exchanges, aiming to curb...
Vitamin D Triggers Autophagy, Improves Diabetes Metabolism
As a medical school professor, I teach students that vitamin D does far more than build bones. This new study shows just how much more. Researchers found that vitamin D supplementation significantly improved glucose tolerance, lowered fasting blood sugar, and reduced...
Biomarker for Differentiating MS From NMOSD Identified in Study
Researchers published in JAMA Neurology identified high‑level EBNA‑1 peptide antibody titers as a robust biomarker that distinguishes relapsing‑remitting multiple sclerosis from MOGAD and seronegative NMOSD. In a cohort of over 1,300 neuroinflammatory patients, persistent EBNA‑1 positivity in at least two...
An Unimpressive Reiki Study
Steven Novella critiques a recent U.S. randomized trial that examined Reiki, placebo Reiki (feiki), mindfulness, and a waitlist for chronic knee osteoarthritis. The study found Reiki reduced symptoms compared to waitlist but not versus feiki, rendering the primary outcome statistically...
Cellular Changes Linked to Depression Related Fatigue
University of Queensland and University of Minnesota researchers identified distinct ATP patterns in the brains and blood cells of young adults with major depressive disorder. The study found that resting cells produce higher ATP levels but cannot increase energy output...
UCB Reports P-III (BE BOLD) Trial Results on Bimzelx (Bimekizumab) in Active Psoriatic Arthritis
UCB announced results from its Phase III BE BOLD trial comparing Bimzelx (bimekizumab) to risankizumab in 553 adults with active psoriatic arthritis. The study met its primary endpoint, showing Bimzelx superior in achieving ACR50 responses at week 16. Bimzelx is...
Gene Therapy for Duchenne Muscular Dystrophy: Genethon Confirms Two-Year Efficacy in Patients Treated with Its Drug Candidate GNT0004 at Therapeutic...
Genethon presented two‑year data from its dose‑escalation phase showing that GNT0004, administered at 3 × 10¹³ vg/kg, produced sustained functional gains and biomarker improvements in ambulatory DMD boys. Motor scores rose 9 points on the NSAA, the 6‑minute walk distance improved by...
Prescribing Mood-Boosting Probiotics Feels Like Magic
Me, during a patient appointment, going over probiotic strains that are evidence-based for mood/anxiety: "I feel like I'm casting Harry Potter spells right now" 🪄
KIMS Hospitals to Raise ₹1,500 Cr Through QIP
Krishna Institute of Medical Sciences (KIMS) Hospitals received board approval to raise up to ₹1,500 crore through a Qualified Institutional Placement (QIP). The capital may be issued in one or more tranches, with the Finance and Investment Committee setting the final...
How to Solve One of the Most Expensive Problems in Employer Healthcare
Employers are turning to diagnostic‑first centers of excellence, such as the Mayo Clinic Complex Care Program, to address costly, undiagnosed conditions among high‑spending employees. By consolidating multidisciplinary evaluations into days rather than months, the model has generated average Year‑1 savings...
Cera’s 300 Billion Data Points to Accelerate Global Medical Research and Healthcare AI
Cera, Europe’s leading digital‑first home‑healthcare provider, announced it has surpassed 300 billion data points collected from more than 2.5 million patient visits each month. The dataset records symptoms, mobility changes, medication responses, nutrition, mood and behavioural signals, creating one of the world’s...
The Evolution of Shared Care Records: From Documents to Conversations
Shared Care Records (SCRs) have progressed from simple document‑exchange portals to intelligent, conversational platforms that actively assist clinicians and patients. The first generation provided read‑only visibility, while the second introduced structured, longitudinal data enabling real‑time contributions. A third phase turned...
Playing Sound Waves to Cells Decreases Laryngeal Cancer Aggressiveness
An international team led by the Turku Bioscience Centre discovered that applying sound‑wave vibration to vocal‑fold cancer cells restores cellular movement and markedly reduces tumor aggressiveness. The mechanical stimulation lowered levels of the oncogenic protein YAP, both in cultured cells...
Keytruda and Padcev Could Become Cancer’s Power Couple
Oncology is moving toward combination regimens, and Merck's Keytruda paired with Pfizer/Astellas' Padcev has emerged as a leading duo. A phase 3 trial in muscle‑invasive bladder cancer showed the combo cut the risk of recurrence, progression and death roughly in half,...
Amazon Brings Health AI to Website, Offers Personalized Care
Will be interesting to see product recommendations on Amazon for those choosing to use Health AI... -> Amazon expands its healthcare AI assistant Health AI to its website and app; the service was previously only available on the app...
Mortality Risk Similar with Tocilizumab, Rituximab in RA-ILD
An emulated target trial using the TriNetX database compared tocilizumab and rituximab in 1,194 rheumatoid arthritis‑associated interstitial lung disease (RA‑ILD) patients each over a five‑year follow‑up. The analysis found no statistically significant difference in all‑cause mortality (15.9% vs 17.7%) or...
Capricor Shares Rise as FDA Sets August Decision Date for Rejected Duchenne Therapy
Capricor Therapeutics announced that the FDA has scheduled an August 22 decision on its investigational Duchenne muscular dystrophy cell therapy, deramiocel, after lifting a prior complete response letter. The biotech resubmitted an enhanced package that includes robust Phase III HOPE‑3 data showing...
Medicaid Loopholes Fuel ABA Therapy Exploitation Crisis
Outstanding WSJ story on the explosion of ABA/autism therapy -fueled by lax Medicaid payment and often non-existent compliance policies, $20/hr RBTs credentialed after a 40-hour online course, and annual staff churn of 50–100%. Our “pay and chase” reimbursement system assumes...
DNA Repair Gene Changes Shape NSCLC Immune Landscape
DNA damage repair gene alterations influence the tumor immune microenvironment in advanced non-small cell lung cancer [Feb 14, 2025] @KamyaSankar et al. @ReckampK Lung Cancer https://t.co/mXZ80zYke3 #lcsm #ImmunoOnc #PrecisionMedicine @TempusAI https://t.co/UJwZnw4qnc
Burnout Common but Regrets Are Not in Allergy, Immunology
The American Academy of Allergy, Asthma & Immunology presented the first allergy and immunology workforce survey since 1998, revealing that 41.7% of clinicians report burnout while most remain satisfied with their careers. Demographically, women now represent 39% of the specialty,...
BRAF Class II/III Mutations Represent Unmet Clinical Need
Real-world clinical genomic analysis of Pts w/ BRAF mutated cancers identifies BRAF class II & III as a population of unmet medical need [3/7/22] Severson et al #ESMO2240P @TempusLabs https://t.co/s5PEBEczlv @Annals_OncologyDOI: https://t.co/c3wxWyUuX0 #PrecisionMedicine #caxtx
Vima Raises $100M to Develop Oral Movement Disorder Drug
With $100M, Vima pursues an oral drug for movement disorders https://t.co/gLrhlYDMSy by @gwendolynawu #biotech #startups
ARTHEx Biotech’s ATX-01 Secures the US FDA Fast Track Designation for Myotonic Dystrophy Type 1
ARTHEx Biotech announced that its RNA‑based drug ATX‑01 has received U.S. FDA Fast Track designation for treating Myotonic Dystrophy Type 1 (DM1). The therapy works by inhibiting miR‑23b, thereby increasing free MBNL protein, correcting splicing errors and reducing toxic DMPK mRNA...
Average-Onset CRC Shows Higher BRAF Mutation Rates
Genomic Landscapes of Early-Onset vs Average-Onset Colorectal Cancer Populations [Feb 28, 2025] Storandt et al. @Cancers_MDPI https://t.co/as7Jolal12 #crcsm #PrecisionMedicine most significant difference b/w eoCRC & aoCRC was higher rates of BRAF mutation among Pts w/ aoCRC https://t.co/7qB4b3A1WK
New Nonprofit Secures $500M to Upgrade Science for AI
New nonprofit launches with at least $500 million to modernize scientific process for AI era https://t.co/yuypno6rVY via @ADeAngelis_bio
UK Health Authorities Join Forces to Champion Foreign Infectious Disease Trials
UK health agencies and the Wellcome charity have launched a joint initiative to fund high‑quality infectious‑disease clinical trials in Africa, South Asia and Southeast Asia. The program, co‑led by the NIHR, the Foreign Commonwealth Development Office and Wellcome, will prioritize...
MIT Professor Hired by RFK Jr Fails Scientific Standards
The MIT professor who has been appointed by Robert F Kennedy Jr to review the safety of Covid-19 vaccines has failed to meet basic scientific standards in his own research on the topic, according to more than a dozen scientists...
Validic Announces Integration with Salesforce Health Cloud to Advance Connected Care and Value-Based Engagement
Validic unveiled a new integration with Salesforce Health Cloud at HIMSS, linking remote patient monitoring and wearable data to the platform's 360-degree patient view. The partnership delivers HIPAA‑compliant, real‑time device data alongside EHR information, enabling health systems, payers, and life‑science...
Dr Haus Dermatology Launches New Consultant-Led Weight Management Service
Dr Haus Dermatology has introduced a consultant‑led medical weight‑management service, headed by endocrinologist Dr Edson Nogueira. Initial consultations occur in person at its Harley Street clinic, with optional video follow‑ups and home delivery of prescribed treatments. The integrated pathway combines...
RA Capital, Forbion and Canaan Appear to Back Harbour's CTLA-4 Partner Solstice
RA Capital, Forbion, and Canaan have collectively invested in Solstice Therapeutics, the CTLA-4 antibody partner of Harbour Therapeutics. The funding round, reportedly a multi‑million dollar Series B, will support Solstice's pre‑clinical and early clinical programs. By backing Solstice, the investors...
Catholic Health’s Duemling Says Cybersecurity Should Be Managed Like a Chronic Condition
In this episode of the Health System CIO Show, CISO Keith Dumling discusses his first year at Catholic Health, emphasizing the importance of listening to the organization’s culture before acting and integrating quick wins into a longer‑term cybersecurity roadmap. He...
Navigating the Patchwork of CME Requirements by State
Physicians practicing across state lines face a fragmented landscape of continuing medical education (CME) mandates, with requirements ranging from zero hours in Montana to 200 hours in Washington over four years. License renewal deadlines also differ widely, tied to birthdays,...
Eurofins Biomnis Launches New Clinical LC‑MS/MS Method for the Detection of Cereulide Toxin in Stool Samples
Eurofins Biomnis has developed and validated a new LC‑MS/MS method to detect and quantify cereulide toxin in human stool samples. The assay meets ISO 15189 requirements, accounting for matrix effects, and delivers turnaround times suitable for routine clinical labs. Cereulide, linked...
Early Data Show Benefits of GLP-1s in Breast Cancer
Early data presented at the San Antonio Breast Cancer Symposium indicate that GLP‑1 receptor agonists, long used for diabetes and obesity, are linked to markedly lower breast cancer recurrence and mortality. Retrospective analyses of thousands of patients showed up to...
Pharma Pulse: FDA Approval of Leucovorin Calcium for CFD and Persistent Inequities in OTC Naloxone Access
The FDA granted its first approval for a therapy targeting cerebral folate transport deficiency, an ultra‑rare neurological disorder, with Wellcovorin (leucovorin calcium) showing meaningful neurological improvements in 89% of patients. Meanwhile, over‑the‑counter naloxone prices have slipped by roughly $0.49 each...
FDA Issues ‘High Risk’ Safety Alert for Radiology Device After 5 Serious Injuries
The FDA issued a high‑risk safety alert for Erbe USA’s flexible cryoprobes used in interventional radiology. The devices can rupture during activation because of insufficient adhesive, producing loud sounds that may cause tinnitus, temporary or permanent hearing loss, and burns....
LucidHealth Rebrands Its Teleradiology Services Division
LucidHealth announced it will rename its teleradiology services division to Lucid Teleradiology, aiming to boost brand visibility and clarify its service offering. The change coincides with appointing Dr. David West as practice president, reinforcing physician leadership. The division currently employs...